Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma
Dustin T. Proctor, Zeel Patel, Sanju Lama, et al.
OncoImmunology (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan, Dongpei Li, Xiao Zhu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109821-109821
Open Access | Times Cited: 543
EANO guideline on the diagnosis and management of meningiomas
Roland Goldbrunner, Pantelis Stavrinou, Michael D. Jenkinson, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 11, pp. 1821-1834
Open Access | Times Cited: 458
B7-H3/CD276: An Emerging Cancer Immunotherapy
Wu-Tong Zhou, Weilin Jin
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 198
B7-H3 Immune Checkpoint Protein in Human Cancer
Karine Flem‐Karlsen, Øystein Fodstad, Caroline E. Nunes‐Xavier
Current Medicinal Chemistry (2019) Vol. 27, Iss. 24, pp. 4062-4086
Closed Access | Times Cited: 62
B7-H3 in Brain Malignancies: Immunology and Immunotherapy
Xiaopeng Guo, Mengqi Chang, Yu Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3762-3780
Open Access | Times Cited: 20
Tumor-associated macrophage infiltration in meningioma
Dustin T. Proctor, Jordan J. Huang, Sanju Lama, et al.
Neuro-Oncology Advances (2019) Vol. 1, Iss. 1
Open Access | Times Cited: 47
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Programmed cell death-ligand 2: new insights in cancer
Yukang Yang, Yan Xia, Xueqi Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3
Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, et al.
Cancers (2018) Vol. 10, Iss. 12, pp. 478-478
Open Access | Times Cited: 35
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
Shirin Karimi, Sheila Mansouri, Yasin Mamatjan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
Swati Sharma, Rashmi Rana, Prem Prakash, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 1, pp. 127-170
Open Access | Times Cited: 9
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
Shuyu Hao, Guanyou Huang, Jie Feng, et al.
Journal of Neuro-Oncology (2019) Vol. 144, Iss. 1, pp. 11-20
Closed Access | Times Cited: 24
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18
Evolving concepts in meningioma management in the era of genomics
Annie L. Hsieh, Wenya Linda Bi, Vijaya Ramesh, et al.
Cancer (2024) Vol. 130, Iss. 15, pp. 2586-2600
Open Access | Times Cited: 2
Persistence of lung structural and functional alterations at one year post‐COVID‐19 is associated with increased serum PD‐L2 levels and altered CD4/CD8 ratio
Ivette Buendía-Roldán, Karen Martínez‐Espinosa, Maria‐Jose Aguirre, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 2
Meningioma: A Pathology Perspective
Angus Toland, Kristin Huntoon, Sonika Dahiya
Neurosurgery (2021) Vol. 89, Iss. 1, pp. 11-21
Open Access | Times Cited: 16
The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas
Giuseppe Roberto Giammalva, Lara Brunasso, Federica Paolini, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3639-3639
Open Access | Times Cited: 12
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 11
Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma
Jiaojiao Deng, Mengyin Ma, Daijun Wang, et al.
World Neurosurgery (2019) Vol. 135, pp. e12-e18
Closed Access | Times Cited: 17
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
Claire Adams, Emanuela Ercolano, Sara Ferluga, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 15
Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas
Jacky T. Yeung, Vesal Yaghoobi, Thazin Nwe Aung, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 2, pp. 150-159
Open Access | Times Cited: 14
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
Atsushi Okano, Satoru Miyawaki, Yu Teranishi, et al.
Neurologia medico-chirurgica (2022) Vol. 62, Iss. 8, pp. 347-360
Open Access | Times Cited: 9
Innovative treatments for meningiomas
Thomas Graillon, Émeline Tabouret, Betty Salgues, et al.
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 449-463
Open Access | Times Cited: 5
Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma
Jiawei Chen, Lingyang Hua, Xiupeng Xu, et al.
World Neurosurgery (2023) Vol. 176, pp. e501-e514
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top